Proprietary Product
TraceWell
The Compliance Backbone for Healthcare Innovation. A proprietary SaaS platform owned and developed by Coyote & Quill.
What It Is
Built to solve the problems we lived with.
TraceWell is not a concept or a prototype. It is a live, actively developed healthcare SaaS platform — built by the same practitioner who navigated HIPAA compliance, FDA 21 CFR Part 11 requirements, and SOC 2 audit readiness simultaneously at a healthcare startup.
The platform is Coyote & Quill's flagship product and the most direct proof that the firm builds what it recommends.
| Product Type | SaaS — Healthcare Technology |
| Owner | Coyote & Quill LLC |
| Patent Status | Filed — USPTO |
| Development | Active — solo developer |
| Target Market | Healthcare providers, pharmacogenomics, preventive care |
Strategic Role
Why TraceWell exists within Coyote & Quill.
Credibility Anchor
Exhibit A
TraceWell is the answer to every client who asks "have you actually built anything?" It is a live product, in active development, with a filed patent. Not a demo. Not a side project.
Revenue Channel
SaaS Licensing
TraceWell operates as a secondary revenue stream alongside consulting engagements — SaaS licensing to healthcare providers and platforms in the firm's target markets.
IP Asset
Defensible Value
The patent establishes proprietary value and defensibility. TraceWell is not competing with generic EHR platforms — it is purpose-built for the compliance and traceability gap in healthcare innovation.
Coming Soon
Full product details, screenshots, and investor one-pager will be added here ahead of launch.
Interested in early access or an investor conversation? Reach out directly.